Canaccord Genuity Group Raises KORU Medical Systems (NASDAQ:KRMD) Price Target to $4.00

KORU Medical Systems (NASDAQ:KRMD) had its price objective increased by analysts at Canaccord Genuity Group from $3.00 to $4.00 in a research report issued on Thursday,Benzinga reports. The firm presently has a “buy” rating on the stock. Canaccord Genuity Group’s target price would suggest a potential upside of 26.18% from the company’s previous close.

A number of other equities research analysts also recently weighed in on the stock. B. Riley initiated coverage on shares of KORU Medical Systems in a research report on Thursday, July 25th. They issued a “buy” rating and a $4.00 price target for the company. Piper Sandler lifted their price objective on KORU Medical Systems from $3.00 to $3.50 and gave the company an “overweight” rating in a report on Thursday.

KORU Medical Systems Stock Up 2.9 %

KRMD opened at $3.17 on Thursday. The company has a debt-to-equity ratio of 0.01, a quick ratio of 3.27 and a current ratio of 3.77. The stock has a fifty day moving average of $2.67 and a 200-day moving average of $2.47. KORU Medical Systems has a fifty-two week low of $1.98 and a fifty-two week high of $3.40. The company has a market capitalization of $145.34 million, a P/E ratio of -12.68 and a beta of 0.41.

Institutional Trading of KORU Medical Systems

Several large investors have recently made changes to their positions in KRMD. Aaron Wealth Advisors LLC bought a new stake in KORU Medical Systems during the second quarter worth $28,000. Allspring Global Investments Holdings LLC bought a new stake in shares of KORU Medical Systems during the 2nd quarter worth $28,000. XTX Topco Ltd acquired a new stake in KORU Medical Systems in the third quarter valued at about $34,000. Legato Capital Management LLC bought a new position in KORU Medical Systems in the second quarter valued at about $35,000. Finally, Virtu Financial LLC bought a new position in KORU Medical Systems in the first quarter valued at about $63,000. Institutional investors and hedge funds own 58.60% of the company’s stock.

About KORU Medical Systems

KORU Medical Systems, Inc develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria.